Latest Articles

Publication Date
Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia - Vera Health

Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia Vera Health

Published: June 18, 2026, 12:22 p.m.
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer - OncLive

Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer OncLive

Published: June 17, 2026, 9:31 p.m.
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer - OncLive

Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer OncLive

Published: June 17, 2026, 9:11 p.m.
Trastuzumab Pamirtecan Produces Durable Responses Across HER2 Expression Levels in Advanced Endometrial Cancer - HMP Global Learning Network

Trastuzumab Pamirtecan Produces Durable Responses Across HER2 Expression Levels in Advanced Endometrial Cancer HMP Global Learning Network

Published: June 17, 2026, 8:26 p.m.
PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer - Medscape Reference

PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer Medscape Reference

Published: June 17, 2026, 2:51 p.m.
Outdoor Air Pollution Linked to Ovarian, Endometrial Cancer - Bioengineer.org

Outdoor Air Pollution Linked to Ovarian, Endometrial Cancer Bioengineer.org

Published: June 16, 2026, 7:15 p.m.
‘How I knew I had endometrial cancer’: Survivors share their stories - UT MD Anderson

‘How I knew I had endometrial cancer’: Survivors share their stories UT MD Anderson

Published: June 16, 2026, 7:05 p.m.
Endometrial Ablation Devices Market growth supported by rising - openPR.com

Endometrial Ablation Devices Market growth supported by rising openPR.com

Published: June 16, 2026, 5:58 a.m.
Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." - La Milano

Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." La Milano

Published: June 16, 2026, 5:13 a.m.
From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 - OncLive

From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 OncLive

Published: June 15, 2026, 12:06 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!